Changes of gene expression profiles in the cervical spinal cord by acupuncture in an MPTP-intoxicated mouse model: Microarray analysis

Gene

Volumn 481, Issue 1, 2011, Pages 7-16

  Choi, Yeong Gon ^a   Yeo, Sujung ^a   Hong, Yeon Mi ^a   Kim, Sung Hoon ^a   Lim, Sabina ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Acupoints; Differentially expressed genes; Gene array; Neurodegeneration; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ACUPUNCTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CERVICAL SPINAL CORD; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; INTOXICATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSONISM; PRIORITY JOURNAL; UPREGULATION;

ACUPUNCTURE; ANIMALS; CERVICAL VERTEBRAE; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; MALE; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; MPTP POISONING; PARKINSONIAN DISORDERS; SPINAL CORD; UP-REGULATION;

EID: 79957667302     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.03.006     Document Type: Article

References (61)

1. Abou-Elhamd A., Cooper O., Münsterberg A. Klhl31 is associated with skeletal myogenesis and its expression is regulated by myogenic signals and Myf-5. Mech. Dev. 2009, 126:852-862.
2. Abraham N.G., Lavrovsky Y., Schwartzman M.L., Stoltz R.A., Levere R.D., Gerritsen M.E., Shibahara S., Kappas A. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc. Natl. Acad. Sci. USA 1995, 92:6798-6802.
3. Akashi S., Shimazu R., Ogata H., Nagai Y., Takeda K., Kimoto M., Miyake K. Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J. Immunol. 2000, 164:3471-3475.
4. An J.H., Lee S.Y., Jeon J.Y., Cho K.G., Kim S.U., Lee M.A. Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J. Proteome Res. 2009, 8:2873-2881.
5. Baek K.H., Mondoux M.A., Jaster R., Fire-Levin E., D'Andrea A.D. DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. Blood 2001, 98:636-642.
6. Balla J., Jacob H.S., Balla G., Nath K., Eaton J.W., Vercellotti G.M. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. USA 1993, 90:9285-9289.
7. Barton P.J., Buckingham M.E. The myosin alkali light chain proteins and their genes. Biochem. J. 1985, 231:249-261.
8. Bernards A., Settleman J. GAP control: regulating the regulators of small GTPases. Trends Cell Biol. 2004, 14:377-385.
9. Bezard E., Dovero S., Bioulac B., Gross C. Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Exp. Neurol. 1997, 148:288-292.
10. Bezard E., Dovero S., Bioulac B., Gross C. Kinetics of nigral degeneration in a chronic model of MPTP-treated mice. Neurosci. Lett. 1997, 234:47-50.
11. Calon F., Grondin R., Morissette M., Goulet M., Blanchet P.J., Di Paolo T., Bédard P.J. Molecular basis of levodopa-induced dyskinesias. Ann. Neurol. 2000, 47:S70-S78.
12. Cheng W.C., Hsieh-Li H.M., Yeh Y.J., Li H. Mice lacking the Obox6 homeobox gene undergo normal early embryonic development and are fertile. Dev. Dyn. 2007, 236:2636-2642.
13. Choi Y.G., Park J.H., Lim S. Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model. Neurosci. Lett. 2009, 450:92-96.
14. Chopra N., Yang T., Asghari P., Moore E.D., Huke S., Akin B., Cattolica R.A., Perez C.F., Hlaing T., Knollmann-Ritschel B.E., Jones L.R., Pessah I.N., Allen P.D., Franzini-Armstrong C., Knollmann B.C. Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc. Natl. Acad. Sci. USA 2009, 106:7636-7641.
15. Dassen H., Kamps R., Punyadeera C., Dijcks F., de Goeij A., Ederveen A., Dunselman G., Groothuis P. Haemoglobin expression in human endometrium. Hum. Reprod. 2008, 23:635-641.
16. Dutta G., Zhang P., Liu B. The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery. Fundam. Clin. Pharmacol. 2008, 22:453-464.
17. Emborg M.E. Evaluation of animal models of Parkinson's disease for neuroprotective strategies. J. Neurosci. Meth. 2004, 139:121-143.
18. Emborg M.E. Nonhuman primate models of Parkinson's disease. ILAR J. 2007, 48:339-355.
19. Erdogan F., Ullmann R., Chen W., Schubert M., Adolph S., Hultschig C., Kalscheuer V., Ropers H.H., Spaich C., Tzschach A. Characterization of a 5.3Mb deletion in 15q14 by comparative genomic hybridization using a whole genome "tiling path" BAC array in a girl with heart defect, cleft palate, and developmental delay. Am. J. Med. Genet. A 2007, 143:172-178.
20. Etminan M., Gill S., Samii A. Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson s disease: a meta-analysis. Drug Saf. 2003, 26:439-444.
21. Gara S.K., Grumati P., Urciuolo A., Bonaldo P., Kobbe B., Koch M., Paulsson M., Wagener R. Three novel collagen VI chains with high homology to the alpha3 chain. J. Biol. Chem. 2008, 283:10658-10670.
22. Garbuzova-Davis S., Saporta S., Haller E., Kolomey I., Bennett S.P., Potter H., Sanberg P.R. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS ONE 2007, 2:e1205.
23. Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J., Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem. Biophys. Res. Commun. 2005, 336:496-506.
24. Goldman N., Chen M., Fujita T., Xu Q., Peng W., Liu W., Jensen T.K., Pei Y., Wang F., Han X., Chen J.F., Schnermann J., Takano T., Bekar L., Tieu K., Nedergaard M. Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat. Neurosci. 2010, 13:883-888.
25. Hamaue N. Pharmacological role of isatin, an endogenous MAO inhibitor. Yakugaku Zasshi 2000, 120:352-362.
26. Harigae H., Suwabe N., Weinstock P.H., Nagai M., Fujita H., Yamamoto M., Sassa S. Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific delta-aminolevulinate synthase gene. Blood 1998, 91:798-805.
27. Hickox D.M., Gibbs G., Morrison J.R., Sebire K., Edgar K., Keah H.H., Alter K., Loveland K.L., Hearn M.T., de Kretser D.M., O'Bryan M.K. Identification of a novel testis-specific member of the phosphatidylethanolamine binding protein family, pebp-2. Biol. Reprod. 2002, 67:917-927.
28. Hong M.S., Park H.K., Yang J.S., Park H.J., Kim S.T., Kim S.N., Park J.Y., Song J.Y., Park H.K., Jo D.J., Park S.W., HwanYun D., Ban J.Y., Chung J.H. Gene expression profile of acupuncture treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease model. Neurol. Res. 2010, 32:74-78.
29. Hwang S.H., Choi Y.G., Jeong M.Y., Hong Y.M., Lee J.H., Lim S. Microarray analysis of gene expression profile by treatment of Cinnamomi Ramulus in lipopolysaccharide-stimulated BV-2 cells. Gene 2009, 443:83-90.
30. Kang J.M., Park H.J., Choi Y.G., Choe I.H., Park J.H., Kim Y.S., Lim S. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Brain Res. 2007, 1131:211-219.
31. Kasture S., Pontis S., Pinna A., Schintu N., Spina L., Longoni R., Simola N., Ballero M., Morelli M. Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease. Neurotox. Res. 2009, 15:111-122.
32. Kim K.I., Giannakopoulos N.V., Virgin H.W., Zhang D.E. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol. Cell. Biol. 2004, 24:9592-9600.
33. Liang L.P., Huang J., Fulton R., Day B.J., Patel M. An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo. J. Neurosci. 2007, 27:4326-4333.
34. Ligeti E., Dagher M.C., Hernandez S.E., Koleske A.J., Settleman J. Phospholipids can switch the GTPase substrate preference of a GTPase-activating protein. J. Biol. Chem. 2004, 279:5055-5058.
35. Lin H.Q., Choi R., Chan K.L., Ip D., Tsim K.W., Wan D.C. Differential gene expression profiling on the muscle of acetylcholinesterase knockout mice: a preliminary analysis. Chem. Biol. Interact. 2010, 187:120-123.
36. Liu L., Zeng M., Stamler J.S. Hemoglobin induction in mouse macrophages. Proc. Natl. Acad. Sci. USA 1999, 96:6643-6647.
37. Luziga C., Nakamura O., Deshapriya R.M., Usui M., Miyaji M., Wakimoto M., Wada N., Yamamoto Y. Expression mapping of cytotoxic T-lymphocyte antigen-2alpha gene transcripts in mouse brain. Histochem. Cell Biol. 2007, 127:569-579.
38. Luziga C., Nakamura O., Deshapriya R.M., Usui M., Miyaji M., Wakimoto M., Wada N., Mbassa G., Yamamoto Y. Dendritic and axonal localization of cytotoxic T-lymphocyte antigen-2 alpha protein in mouse brain. Brain Res. 2008, 1204:40-52.
39. Malakhov M.P., Kim K.I., Malakhova O.A., Jacobs B.S., Borden E.C., Zhang D.E. High-throughput immunoblotting. Ubiquitin-like protein ISG15 modifies key regulators of signal transduction. J. Biol. Chem. 2003, 278:16608-16613.
40. Meredith G.E., Kang U.J. Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Mov. Disord. 2006, 21:1595-1606.
41. Nakajima O., Takahashi S., Harigae H., Furuyama K., Hayashi N., Sassa S., Yamamoto M. Heme deficiency in erythroid lineage causes differentiation arrest and cytoplasmic iron overload. EMBO J. 1999, 18:6282-6289.
42. Neef C., van Laar T. Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease. Clin. Pharmacokinet. 1999, 37:257-271.
43. Newton D.A., Rao K.M., Dluhy R.A., Baatz J.E. Hemoglobin is expressed by alveolar epithelial cells. J. Biol. Chem. 2006, 281:5668-5676.
44. Oda M., Haruta H., Nagao M., Nagata Y. Isolation and characterization of mouse homolog of the neutrophil activating peptide-2. Biochem. Biophys. Res. Commun. 2002, 290:865-868.
45. Pardridge W.M. Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy. NeuroRx 2005, 2:129-138.
46. Park H.J., Lim S., Joo W.S., Yin C.S., Lee H.S., Lee H.J., Seo J.C., Leem K., Son Y.S., Kim Y.J., Kim C.J., Kim Y.S., Chung J.H. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. Exp. Neurol. 2003, 180:93-98.
47. Rabinstein A.A., Shulman L.M. Acupuncture in clinical neurology. Neurologist 2003, 9:137-148.
48. Samantaray S., Knaryan V.H., Butler J.T., Ray S.K., Banik N.L. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP. J. Neurochem. 2008, 104:1309-1320.
49. Shi H., Scheffler J.M., Pleitner J.M., Zeng C., Park S., Hannon K.M., Grant A.L., Gerrard D.E. Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. FASEB J. 2008, 22:2990-3000.
50. Sit S.Y. Dopamine agonists in the treatment of Parkinson's disease past, present and future. Curr. Pharm. Des. 2000, 6:1211-1248.
51. Söderhäll C., Marenholz I., Kerscher T., Rüschendorf F., Esparza-Gordillo J., Worm M., Gruber C., Mayr G., Albrecht M., Rohde K., Schulz H., Wahn U., Hubner N., Lee Y.A. Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis. PLoS Biol. 2007, 5:e242.
52. van Rooij E., Quiat D., Johnson B.A., Sutherland L.B., Qi X., Richardson J.A., Kelm R.J., Olson E.N. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell 2009, 17:662-673.
53. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579.
54. Whishaw I.Q., Gorny B., Sarna J. Paw and limb use in skilled and spontaneous reaching after pyramidal tract, red nucleus and combined lesions in the rat: behavioral and anatomical dissociations. Behav. Brain Res. 1998, 93:167-183.
55. Wooldridge A.A., Fortner C.N., Lontay B., Akimoto T., Neppl R.L., Facemire C., Datto M.B., Kwon A., McCook E., Li P., Wang S., Thresher R.J., Miller S.E., Perriard J.C., Gavin T.P., Hickner R.C., Coffman T.M., Somlyo A.V., Yan Z., Haystead T.A. Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle. J. Biol. Chem. 2008, 283:11850-11859.
56. Wride M.A., Mansergh F.C., Adams S., Everitt R., Minnema S.E., Rancourt D.E., Evans M.J. Expression profiling and gene discovery in the mouse lens. Mol. Vis. 2003, 9:360-396.
57. Xing G.G., Liu F.Y., Qu X.X., Han J.S., Wan Y. Long-term synaptic plasticity in the spinal dorsal horn and its modulation by electroacupuncture in rats with neuropathic pain. Exp. Neurol. 2007, 208:323-332.
58. Yano R., Yokoyama H., Kuroiwa H., Kato H., Araki T. A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice. J. Mol. Neurosci. 2009, 39:211-219.
59. Yuan Y., Liu J., Liu Z., He Y., Zhang Z., Jiang C., Qian Q. Chemokine CCL3 facilitates the migration of hepatoma cells by changing the concentration intracellular Ca. Hepatol. Res. 2010, 40:424-431.
60. Zhao C., Beaudenon S.L., Kelley M.L., Waddell M.B., Yuan W., Schulman B.A., Huibregtse J.M., Krug R.M. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc. Natl. Acad. Sci. USA 2004, 101:7578-7582.
61. Zhong Z., Deane R., Ali Z., Parisi M., Shapovalov Y., O'Banion M.K., Stojanovic K., Sagare A., Boillee S., Cleveland D.W., Zlokovic B.V. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 2008, 11:420-422.